New York State Common Retirement Fund’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Hold
43,422
﹤0.01% 2141
2025
Q4
$341K Hold
43,422
﹤0.01% 2098
2025
Q3
$353K Hold
43,422
﹤0.01% 2068
2025
Q2
$203K Hold
43,422
﹤0.01% 2248
2025
Q1
$238K Buy
43,422
+20,600
+90% +$83.2K ﹤0.01% 2158
2024
Q4
$77.4K Hold
22,822
﹤0.01% 2700
2024
Q3
$65K Hold
22,822
﹤0.01% 2776
2024
Q2
$51.4K Buy
22,822
+38
+0.2% +$77 ﹤0.01% 3081
2024
Q1
$50.4K Sell
22,784
-91
-0.4% -$235 ﹤0.01% 2980
2023
Q4
$53.8K Sell
22,875
-260
-1% -$480 ﹤0.01% 2973
2023
Q3
$43K Buy
23,135
+463
+2% +$1.06K ﹤0.01% 3062
2023
Q2
$59.4K Sell
22,672
-115
-0.5% -$293 ﹤0.01% 3097
2023
Q1
$37.1K Sell
22,787
-69,700
-75% -$87.3K ﹤0.01% 3054
2022
Q4
$123K Sell
92,487
-13
-0% -$18 ﹤0.01% 2903
2022
Q3
$144K Buy
92,500
+1,100
+1% +$1.82K ﹤0.01% 2894
2022
Q2
$141K Buy
+91,400
New +$193K ﹤0.01% 2951
2021
Q3
Sell
-368
Closed -$1K 3540
2021
Q2
$1K Sell
368
-30,389
-99% -$116K ﹤0.01% 3487
2021
Q1
$139K Buy
30,757
+10,800
+54% +$58.2K ﹤0.01% 2970
2020
Q4
$98K Buy
19,957
+2,500
+14% +$12.5K ﹤0.01% 3034
2020
Q3
$104K Hold
17,457
﹤0.01% 2907
2020
Q2
$46K Hold
17,457
﹤0.01% 3161
2020
Q1
$34K Hold
17,457
﹤0.01% 3051
2019
Q4
$123K Sell
17,457
-11,600
-40% -$95.8K ﹤0.01% 2943
2019
Q3
$286K Buy
29,057
+8,400
+41% +$94.4K ﹤0.01% 2592
2019
Q2
$236K Buy
20,657
+16,757
+430% +$176K ﹤0.01% 2737
2019
Q1
$39K Hold
3,900
﹤0.01% 3096
2018
Q4
$66K Buy
+3,900
New +$78.2K ﹤0.01% 3057

Other funds holding XERS